In breast cancer, upregulation of BIRC3 could lead to tumor anti-apoptosis and poor prognosis (Hahm & Singh, 2013; Mendoza-Rodríguez et al., 2017; Srour et al., 2020). Here, BIRC3 is linked to breast cancer.